Abstract

Microglia plays a critical role in neuroinflammation after ischemic stroke by releasing diverse inflammatory cytokines. Long non-coding RNA taurine up-regulated gene 1 (lncRNA TUG1) is widely expressed in adult brain and has been reported to participate in multiple biological processes associated with nervous system diseases. However, the role of TUG1 in microglial activation remains unidentified. BV-2 microglial cells were cultured in vitro and TUG1 siRNA was used to knock down its RNA level. Microglial cells were subjected to oxygen-glucose deprivation (OGD) for 4 h following TUG1 siRNA or scramble siRNA transient transfection. After 24 h reoxygenation, TUG1 level and microglial M1/M2 phenotype, as well as releasing inflammatory cytokines and their role to viability of SH-SY5Y neuroblastoma cells were determined by quantitative real-time PCR (qRT-PCR), ELISA, immunofluorescence and western blot. In addition, miR-145a-5p, a putative microRNA to bind with TUG1 by bioinformatics analysis, was simultaneously examined, then the interaction of TUG1 with miR-145a-5p and the potential involvement of NF-κB pathway were further evaluated by RNA-RNA pull-down assay and western blot. The cellular level of TUG1 was transiently up-regulated in microglial cells 24 h after OGD treatment, with an inverse correlation to downregulated miR-145a-5p. TUG1 knockdown drove microglial M1-like to M2-like phenotypic transformation with reduced production of pro-inflammatory cytokines (tumor necrosis factor-α, TNF-α; interleukin-6, IL-6) and incremental release of anti-inflammatory cytokine (interleukin-10, IL-10), as a result, promoted the survival of SH-SY5Y cells. Meanwhile, TUG1 knockdown prevented OGD-induced activation of NF-κB pathway as well, represented by decreased ratios of p-p65/p65 and p-IκBα/IκBα proteins. Furthermore, we found that TUG1 could physically bind to miR-145a-5p while miR-145a-5p inhibitor abolished the protective effects of TUG1 knockdown through activation of NF-κB pathway, suggesting a negative interaction between TUG1 and miR-145a-5p. Our study demonstrated that lncRNA TUG1, sponging miR-145a-5p with negative interaction, could regulate microglial polarization and production of inflammatory cytokines at a relatively early stage after OGD insult, where NF-κB pathway might be involved, possibly providing a promising therapeutic target against inflammatory injury.

Highlights

  • Ischemic stroke is one of the leading causes of death and disability worldwide, with limited treatment options available (Powers et al, 2018)

  • Thereby, we focus on the interaction between taurine up-regulated gene 1 (TUG1) and miRNAs

  • We explored the functional involvement of TUG1 in microglial polarization and their regulation to NF-κB pathway, a well-known inflammatory mediator

Read more

Summary

Introduction

Ischemic stroke is one of the leading causes of death and disability worldwide, with limited treatment options available (Powers et al, 2018). The post-ischemic inflammation is conventionally considered detrimental to brain parenchyma and previous studies of neuroprotective therapies mainly focused on preventing the functions of immune cells and inflammatory mediators. Increasing evidence indicates that post-ischemic inflammation could be beneficial by alleviating neuronal apoptosis and strengthening neurogenesis, exclusive suppression of which may compromise the neuroprotective effects (Jin et al, 2013; Fu et al, 2015). LncRNA taurine up-regulated gene 1 (TUG1), a taurine-induced lncRNA essential to the forming of photoreceptors in retinal development (Young et al, 2005), was up-regulated in brain ischemic penumbra and sponged microRNA-9 to promote neuronal apoptosis (Chen et al, 2017). Thereby, we focus on the interaction between TUG1 and miRNAs

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.